IL1A and Ito hypomelanosis: Indeed, the results presented suggest that targeting immune signalling (like that of IL-1α) could help reduce hypoxia and improve the outcomes of IPA; however, whether targeting host factors to modulate inflammation and hypoxia is a viable method of treatment for IPA in humans is still to be determined.